|
|||||
|
|
Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses |
|
| Authors: | Jose M Ruiz-Moreno Javier A Montero Pedro Amat-Peral |
| Institution: | 1.Department of Ophthalmology,Castilla La Mancha University,Albacete,Spain;2.Alicante Institute of Ophthalmology,VISSUM, Vitreo-Retinal Unit,Alicante,Spain;3.Pio del Rio Hortega Hospital,University of Valladolid,Valladolid,Spain;4.Departamento de Ciencias Médicas,Facultad de Medicina,Albacete,Spain |
| Abstract: | BackgroundMyopic maculopathy is the leading cause of subfoveal choroidal neovascularization (CNV) in patients under 50 years of age. New antiangiogenic drugs are being used off-label with varied therapeutic schedules to treat CNV. The aim of this study is to report the anatomical and visual outcomes of myopic choroidal neovascularization (CNV) treated by two different schedules with intravitreal bevacizumab. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |